| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90834 |
Psychotherapy, 45 minutes with patient |
318,268 |
198,168 |
$16.82M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
59,469 |
56,098 |
$3.88M |
| 90791 |
Psychiatric diagnostic evaluation |
39,639 |
38,761 |
$3.69M |
| T1023 |
Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter |
6,518 |
4,065 |
$2.77M |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
9,797 |
9,642 |
$1.68M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
39,556 |
38,378 |
$1.59M |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
11,894 |
11,873 |
$1.50M |
| H2011 |
Crisis intervention service, per 15 minutes |
2,034 |
1,407 |
$1.46M |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
24,974 |
20,163 |
$1.45M |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
6,554 |
6,450 |
$542K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
13,249 |
13,001 |
$523K |
| 90832 |
Psychotherapy, 30 minutes with patient |
13,245 |
11,921 |
$511K |
| 90837 |
Psychotherapy, 53 minutes with patient |
6,510 |
4,486 |
$496K |
| T1017 |
Targeted case management, each 15 minutes |
4,455 |
2,975 |
$459K |
| H0032 |
Mental health service plan development by non-physician |
4,909 |
4,860 |
$425K |
| S9484 |
Crisis intervention mental health services, per hour |
483 |
219 |
$340K |
| H0031 |
Mental health assessment, by non-physician |
2,721 |
2,704 |
$299K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
6,351 |
2,501 |
$98K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,070 |
2,056 |
$64K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
393 |
388 |
$49K |
| 99215 |
Prolong outpt/office vis |
409 |
378 |
$40K |
| 99443 |
|
334 |
321 |
$11K |
| 99442 |
|
445 |
443 |
$10K |
| 80305 |
|
768 |
579 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
216 |
206 |
$4K |
| 99441 |
|
90 |
90 |
$627.59 |